Literature DB >> 33349575

How do adenosine A2A receptors regulate motor function?

Akihisa Mori1.   

Abstract

Adenosine A2A receptor antagonism is a new therapeutic strategy in the symptomatic treatment of Parkinson's disease (PD). This review addresses how adenosine A2A receptors are involved with the control of motor function via the basal ganglia-thalamocortical circuit, and considers the anatomical localization and physiological function of the receptor, along with its ultrastructural localization in critical areas/neurons of the circuit. Based on this understanding of the functional significance of the adenosine A2A receptor in the basal ganglia, the mode of action of A2A receptor antagonists is explored in terms of the dynamic functioning of the basal ganglia and the activity of the internal circuits of the striatum in PD. Finally, the pathophysiological differences between the normal and PD states are examined to emphasize the importance of the adenosine A2A receptor.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  A(2A) receptor antagonist; Adenosine; Adenosine A(2A) receptor; Basal ganglia; Cyclic AMP; Parkinson's disease; Striatopallidal pathway

Year:  2020        PMID: 33349575     DOI: 10.1016/j.parkreldis.2020.09.025

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  3 in total

Review 1.  Metabolic Aspects of Adenosine Functions in the Brain.

Authors:  Mercedes Garcia-Gil; Marcella Camici; Simone Allegrini; Rossana Pesi; Maria Grazia Tozzi
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

Review 2.  The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease.

Authors:  Akihisa Mori; Jiang-Fan Chen; Shinichi Uchida; Cecile Durlach; Shelby M King; Peter Jenner
Journal:  Molecules       Date:  2022-04-06       Impact factor: 4.411

Review 3.  Istradefylline for OFF Episodes in Parkinson's Disease: A US Perspective of Common Clinical Scenarios.

Authors:  Stuart H Isaacson; Sagari Betté; Rajesh Pahwa
Journal:  Degener Neurol Neuromuscul Dis       Date:  2022-07-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.